Literature DB >> 3125406

Abnormalities in lipoprotein metabolism in Gaucher type 1 disease.

N A Le1, J C Gibson, A Rubinstein, G A Grabowski, H N Ginsberg.   

Abstract

We have previously described an association between Gaucher type 1 disease and reduced levels of total, low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol. Plasma concentrations of apolipoprotein B and apolipoprotein AI were reduced in these subjects, while plasma apolipoprotein E (apoE), which can be synthesized and secreted by macrophages, was increased. To study the pathophysiologic basis for these changes in lipoprotein and apolipoprotein levels, we studied very low density lipoprotein (VLDL), LDL, and HDL metabolism in-depth in four subjects with Gaucher disease. Gel filtration of their plasma revealed that apoE was present in essentially a single population of lipoproteins in the large HDL range. In subject no. 4, studied presplenectomy and post-splenectomy, plasma apoE levels fell after surgery in association with a redistribution of apoE among the plasma lipoproteins to a pattern seen in normal subjects. Determination of the rates of secretion and catabolism of VLDL apoB and triglyceride were within normal limits. The reduced plasma levels of LDL and HDL cholesterol, and of both plasma apoB and apoAI, were associated with increased fractional catabolic rates of these apolipoproteins in LDL and HDL. These results indicate that the hypocholesterolemia present in subjects with Gaucher type 1 disease is associated with increased fractional catabolism of LDL and HDL. These findings, together with the evidence for alternations in plasma apoE metabolism in this disorder, suggest a role for the macrophage as the basis for these abnormalities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125406     DOI: 10.1016/0026-0495(88)90102-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study.

Authors:  Anca Zimmermann; Paula Grigorescu-Sido; Heidi Rossmann; Karl J Lackner; Cristina Drugan; Camelia Al Khzouz; Simona Bucerzan; Ioana Naşcu; Tim Zimmermann; Daniel Leucuţa; Matthias M Weber
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

2.  Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

Authors:  Hiroki Mizukami; Yide Mi; Ryuichi Wada; Mari Kono; Tadashi Yamashita; Yujing Liu; Norbert Werth; Roger Sandhoff; Konrad Sandhoff; Richard L Proia
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity.

Authors:  Philip Stein; Ruhua Yang; Jun Liu; Gregory M Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2011-02-03       Impact factor: 4.982

4.  Plasma lipid levels of rats fed a diet containing pork fat as a source of lipids after splenic surgery.

Authors:  Ana Paula Gonçalves Dinis; Ruy Garcia Marques; Fernanda Correia Simões; Cristina Fajardo Diestel; Carlos Eduardo Rodrigues Caetano; Dióscuro José Ferreira Secchin; José Firmino Nogueira Neto; Margareth Crisóstomo Portela
Journal:  Lipids       Date:  2009-05-05       Impact factor: 1.880

Review 5.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

6.  NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.

Authors:  Fay Probert; Victor Ruiz-Rodado; Danielle Te Vruchte; Elena-Raluca Nicoli; Tim D W Claridge; Christopher A Wassif; Nicole Farhat; Forbes D Porter; Frances M Platt; Martin Grootveld
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

Review 7.  The role of splenectomy in lipid metabolism and atherosclerosis (AS).

Authors:  Xiao-Ming Ai; Li-Chen Ho; Lu-Lu Han; Jin-Jing Lu; Xiong Yue; Nian-Yin Yang
Journal:  Lipids Health Dis       Date:  2018-08-16       Impact factor: 3.876

8.  High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease.

Authors:  Tamar H Taddei; James Dziura; Shu Chen; Ruhua Yang; Hideyuki Hyogo; Cameron Sullards; David E Cohen; Gregory Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-03-31       Impact factor: 4.982

9.  Nonalcoholic fatty liver disease progression in rats is accelerated by splenic regulation of liver PTEN/AKT.

Authors:  Ziming Wang; Naishu Li; Biao Wang; Jianhua Lin
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.